Effects of sodium–glucose cotransporter 2 inhibitors in addition to insulin therapy on cardiovascular risk factors in type 2 diabetes patients: A meta‐analysis of randomized controlled trials

AIMS/INTRODUCTION: In the present meta‐analysis, we aimed to determine the effects of sodium–glucose cotransporter 2 inhibitor (SGLT‐2i) in addition to insulin therapy on cardiovascular risk factors in type 2 diabetes patients. MATERIALS AND METHODS: Randomized controlled trials were identified by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bingshu, Zheng, Hongzhi, Gu, Jianqiu, Guo, Yan, Liu, Yixuan, Wang, Yingfang, Chen, Feng, Yang, Aolin, Wang, Jiabei, Wang, Hailong, Liu, Ying, Wang, Difei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400156/
https://www.ncbi.nlm.nih.gov/pubmed/29923322
http://dx.doi.org/10.1111/jdi.12876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400156/
https://www.ncbi.nlm.nih.gov/pubmed/29923322
http://dx.doi.org/10.1111/jdi.12876

Ejemplares similares